CRISPR Therapeutics AG - Common Shares (CRSP)

This little company's scientific breakthrough opened up a whole new sliver of the drug market (although it's still leading the developmental race).

The global economy in 2025 is navigating a landscape profoundly reshaped by the escalating demands of Artificial Intelligence (AI) and transformative shifts in healthcare. While the burgeoning energy consumption of AI data centers is putting unprecedented strain on power grids and catalyzing a new wave of investment across traditional and

The global economy is sailing into Q3 2025 with a blend of cautious optimism and persistent challenges. While a new tariff regime and elevated geopolitical tensions introduce elements of uncertainty, the underlying currents suggest continued, albeit slower, economic expansion, particularly within the United States. Investors are keenly watching the interplay

Cathie Wood's ARK Innovation ETF is outperforming tech market again in 2025, driven by AI breakthroughs and the return of inflows.

This biotech's innovative approach could pay rich dividends down the road.

Ark Invest has six main ETFs with several around for more than 10 years. A look at the top 10 holdings across the six funds and what it could mean.

Cathie Wood-led Ark Invest executed a significant trade in Block Inc. (NYSE:XYZ) on Tuesday.

This biotech's innovative ways might eventually pay off.

As time marches on, the factors that could make or break this stock are becoming crystal clear.

Ark Invest traded in VCYT, IRDM, CRSP, KTOS, ABSI, VEEV, ADPT, and GH. Mainly focused on healthcare innovation.

During the pandemic-fueled boom of 2020, Cathie Wood's Ark Innovation ETF (NYSE:ARKK) was one of the hottest funds on Wall Street, surging nearly 400% off its March 2020 lows. But that euphoria peaked in February 2021.

U.S. stocks were mixed, with the Dow Jones index falling around 50 points on Friday.

These companies have compelling long-term futures, but the coming decade could prove particularly exciting as each one comes into its own.

Each of these 10 businesses offers a market-leading product or service within an industry that's set to explode.

Cathie Wood's Ark Investment Management has filed plans to launch four new exchange-traded funds designed to offer downside protection for investors in its flagship ARK Innovation ETF (BATS: ARKK), while placing a cap on potential gains.

These companies are poised to produce fireworks for your portfolio over the coming years.

The 2025 TIME 100 Most Influential Companies list includes over 40 companies that investors can buy stock in.

FDA launches review of trials that sent American DNA to China without full consent; NIH investigates impact of Biden-era exemption on federally funded research

Nicole Verdun and Rachael Anatol were placed on administration leave without explanation.

Lilly's Verve acquisition lifts sentiment in gene editing stocks, with analysts calling it a strategic and timely move in a tough funding climate.